4 research outputs found

    Chlorhexidine: a hidden life-threatening allergen

    Get PDF
    Chlorhexidine is a commonly used antiseptic and disinfectant in the health-care setting. Anaphylaxis to chlorhexidine is a rare but potentially life-threatening complication. Epidemiologic data suggest that the cases of chlorhexidine allergy appears to be increasing. In this article we report a life-threatening anaphylactic shock with cardiorespiratory arrest, during urethral catheterization due to chlorhexidine. The authors also performed a literature review of PubMed library of anaphylactic cases reports due to this antiseptic between 2014 and 2018, demonstrating the increase in the number of cases occurring worldwide and the importance of detailed anamnesis and appropriate diagnostic workup of allergic reactions to disinfectants.info:eu-repo/semantics/publishedVersio

    O PAPEL DO OMALIZUMAB NA DERMATITE ATÓPICA GRAVE

    Get PDF
    We present the cases of two young females with severe atopic dermatitis, treated with anti-histamines, topical corticosteroids, high-dose systemic corticosteroids bursts and/or oral cyclosporine, without significant improvement and worsening with tapering of corticosteroids and/or cyclosporine. Several therapeutical adjustments were made without success before starting treatment with subcutaneous omalizumab. The clinical evolution of these patients undergoing treatment with omalizumab is described and its role in the treatment of atopic dermatitis is discussed.Apresentam-se os casos de duas jovens, com diagnĂłstico de dermatite atĂłpica grave medicadas com anti-histamĂ­nicos orais, corticĂłides tĂłpicos, ciclos de corticoterapia sistĂ©mica em doses elevadas e/ou ciclosporina oral, sem melhoria e com agravamento clĂ­nico apĂłs redução da dose de corticĂłides sistĂ©micos e/ou da ciclosporina. Na consulta de imunoalergologia efectuaram-se vĂĄrios reajustes terapĂȘuticos sem sucesso antes de iniciar terapĂȘutica com omalizumab subcutĂąneo. Descreve-se a evolução clĂ­nica destas 2 doentes sob terapĂȘutica com omalizumab e discute-se o seu papel no tratamento da dermatite atĂłpica
    corecore